Myriad Genetics (MYGN) Stock: Buy, Sell, or Hold?
MYGN - Myriad Genetics Inc
$4.54
0.48 (11.82%)
▲
5d:
+8.87%
30d:
+40.56%
90d:
-24.71%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 02, 2026
29d
Get Alerted When MYGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MYGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MYGN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MYGN is currently trading at $4.54, which is considered extended relative to its 30-day fair value range of $3.20 to $4.13. From a valuation perspective, the stock is trading at a discount (Forward PE: -7.8) compared to its historical average (50.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MYGN is in a downtrend. The price is approaching resistance at $4.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.8% recently.
Market Sentiment: MYGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $3.41. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYGN is in a downtrend. The price is approaching resistance at $4.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.8% recently.
Market Sentiment: MYGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $3.41. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.20 -
$4.13
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Protect Your Profits
Holding MYGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.9% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.8%)
- BEARISH: Trading 24.8% above Wall St target ($3.41)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.20 -
$4.13
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.76
Resistance Level
$4.59
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.80
Wall Street Target
$3.41
(-24.8%)
Revenue Growth (YoY)
-10.5%
Profit Margin
-14.0%
PE vs Historical
-7.8 vs 50.8
CHEAP
Share & Embed Analysis
Last updated: October 03, 2026 6:14 PM ET
Data refreshes hourly during market hours. Next update: 7:14 PM
Data refreshes hourly during market hours. Next update: 7:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 48 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 67 BUY |
Advanced MYGN Option Strategies
Professional options setups generated by AI based on today's MYGN price and gamma walls.
